Cannabis, CBD, CBG, Hemp Benefits
CBD and Menopause: The Conversation Medicine Has Been Too Slow to Have
Women’s Health · CBD · CBG · Menopause
About 1.3 million women enter menopause every year in the United States. Most of them will navigate hot flashes, broken sleep, joint pain, anxiety, and brain fog, often with limited support from a medical system that has historically underfunded women’s health research. A growing number are quietly turning to cannabinoids. Here’s what the science actually says.
Menopause is not a disease. It’s a biological transition, and one that can be seriously disruptive, lasting anywhere from two to ten years and touching nearly every system in the body. The drop in estrogen doesn’t just affect the reproductive system, either. Estrogen receptors exist in the brain, the bones, the joints, the cardiovascular system, and the skin. When estrogen declines, all of those systems feel it.
The conventional medical toolkit includes hormone replacement therapy (HRT), which works well for many women, alongside a range of symptom-specific medications. Still, a real gap exists between what’s available and what women actually need. Research from the University of Alberta found that one in three women use cannabis to manage menopause symptoms, with nearly two-thirds of the 1,500 women surveyed reporting they’d used it at some point during their transition.
Most aren’t waiting for a prescription. Women are figuring this out on their own, which is exactly why the conversation needs to happen more openly.
What Menopause Actually Does to Your Body
To understand what cannabinoids are being asked to do, it helps to map out what menopause actually disrupts. These symptoms aren’t just uncomfortable. A hormonal system is being fundamentally reorganized, and the downstream effects touch almost everything.
Hot Flashes & Night Sweats
Affect up to 80% of women. Triggered by the hypothalamus misreading body temperature, an estrogen-linked regulation failure.
Sleep Disruption
Night sweats interrupt sleep architecture. Lower estrogen also directly affects the sleep-wake cycle and melatonin regulation.
Anxiety & Mood Changes
Estrogen modulates serotonin and dopamine. Up to 70% of women experience mood fluctuations during the transition.
Joint Pain & Inflammation
Estrogen has natural anti-inflammatory properties. 70% of women report musculoskeletal symptoms during perimenopause and menopause.
Brain Fog
Memory lapses and difficulty concentrating are reported by a significant portion of women, linked directly to estrogen’s role in neural function.
Bone Density Loss
Estrogen helps regulate bone turnover. Post-menopause, bone loss accelerates significantly, raising osteoporosis risk.
A common thread runs through many of these symptoms: inflammation, disrupted neurotransmitter balance, and a nervous system running at a higher state of alert than it needs to be. Those are the areas where the endocannabinoid system, and cannabinoids like CBD and CBG, have the most research behind them.
What CBD Can Do, By Symptom
CBD doesn’t target menopause directly. No study shows it reverses hormonal decline. What it does is address the systems that menopause disrupts, and that’s a real distinction worth keeping in mind.
For anxiety and mood: CBD interacts with the 5-HT1A serotonin receptor, the same receptor pathway estrogen helps regulate. When estrogen drops and serotonin regulation falters, CBD may help compensate. A large clinical case series found CBD reduced anxiety in 79% of patients within the first month. That study wasn’t specific to menopausal women, but the mechanism maps directly onto what menopause does to the serotonin system.
For sleep: Menopause-related insomnia has two main drivers: night sweats that physically interrupt sleep, and anxiety that prevents the nervous system from settling. The same clinical series found two-thirds of patients reported improved sleep quality within the first month of CBD use. CBD works best for anxiety-driven insomnia, the kind where the mind won’t stop running after a hot flash wakes you up at 2am.
For joint pain: One of CBD’s better-supported use cases overall. A Northwell Health study on CBD for joint pain found more than 80% of participants reported reduced pain, with two-thirds experiencing improved physical function. CBD’s anti-inflammatory action via CB2 receptors and inhibition of inflammatory signaling aligns well with menopause-related joint pain: inflammation that estrogen would normally keep in check, suddenly unchecked.
For hot flashes: The evidence here is mostly anecdotal. A theoretical basis exists since CBD’s interaction with serotonin receptors plays a role in temperature regulation, but clinical studies specifically on CBD and hot flashes are still lacking. Women report relief. The science hasn’t yet formally confirmed the mechanism.
CBG: The One Researchers Are Watching Closely
CBD is the well-known cannabinoid. CBG, cannabigerol, is the one scientists are increasingly focused on, and for menopausal women specifically, the research trajectory is hard to ignore.
Sometimes called the “mother of all cannabinoids,” CBG is the precursor from which CBD, THC, and most other cannabinoids are synthesized. Like CBD, it produces no intoxication. Unlike CBD, it hits different receptor targets and produces notably different effects.
In July 2024, Washington State University published the first human clinical trial on CBG’s effects on anxiety and stress. Results showed 20mg of hemp-derived CBG reduced feelings of anxiety at 20, 45, and 60 minutes after ingestion compared to placebo. Stress ratings also decreased. Then came the result that surprised even the researchers: CBG significantly enhanced verbal memory recall. Participants remembered more words after taking CBG than after taking a placebo.
No cognitive impairment. No intoxication. Anxiety down. Memory up.
For women navigating brain fog and anxiety during menopause, that profile is hard to overlook. Lead researcher Professor Carrie Cuttler has since announced a planned follow-up study examining CBG’s effects on menopause symptoms specifically. The scientific community is connecting the same dots.
Related Reading
CBG is also gaining traction among athletes for recovery and focus, a different context that shows the same anti-inflammatory and anxiolytic profile at work. See our piece on why athletes are switching from CBD to CBG for more on how this cannabinoid is being used in performance settings.
CBG and Inflammation: The Joint Pain Connection
Beyond anxiety, CBG carries a strong anti-inflammatory profile that makes it relevant to menopause-related joint pain. Preclinical research shows CBG inhibits the COX-1 and COX-2 enzymes, the same enzymes that common anti-inflammatories like ibuprofen target, as well as iNOS, a signaling molecule that drives inflammation.
CBD primarily works through CB2 receptors. CBG hits multiple pathways at once: CB1, CB2, TRP channels, and the COX enzyme system, giving it a broader anti-inflammatory reach. For joint stiffness and musculoskeletal pain arriving with estrogen decline, that multi-target action may matter more than either compound alone.
Both CBD and CBG interact with the endocannabinoid system’s CB2 receptors, which appear throughout the joints, immune system, and bone tissue. Because the ECS plays a role in bone metabolism, the Rutgers finding on improved bone metabolism in CBD-treated mice is worth watching. Researchers are beginning to take the bone density question more seriously.
Why Medicine Is Behind on This
The reason this conversation hasn’t happened more openly in medical settings is structural, not scientific. Cannabis held a Schedule I classification for over 50 years. Women’s health research faced chronic underfunding for decades. The intersection of the two, cannabinoids for menopause, attracted almost no institutional attention until very recently.
A systematic review of the literature on cannabis and menopause found only three studies meeting rigorous inclusion criteria and concluded that research into cannabis consumption in menopause is “essential, as it is frequently used to alleviate symptoms without evidence of its benefits.” That conclusion isn’t a dismissal. It’s a recognition that the evidence gap is the problem, not the practice itself.
The WSU CBG-menopause study is now in development. Rutgers is publishing CBD-menopause preclinical data. The University of Alberta is surveying cannabis use in menopause at scale. Research infrastructure is finally catching up to what women have been doing quietly for years.
A Practical Starting Point
Thinking about adding CBD or CBG to your menopause routine? Here’s what the current evidence actually supports:
For anxiety and mood: CBD is the better-studied option. A sublingual tincture offers faster onset and adjustable dosing, useful when anxiety spikes are unpredictable. Start low at 10 to 15mg and adjust from there.
For sleep: CBD works best for anxiety-driven insomnia. Timing matters: a tincture about 30 minutes before bed, or a gummy 60 to 90 minutes beforehand. An evening CBD tea builds its own calming ritual that compounds the biochemical effect.
For joint pain: Topical CBD is well-supported for localized pain, acting directly at the site without systemic effects. For broader, whole-body inflammation, an oral CBD or CBG product is the better route.
For brain fog: CBG is the more interesting option, based on the 2024 WSU trial. The memory-enhancing effect alongside anxiety reduction is a profile worth paying attention to, even with the research still early.
One note: if you’re on HRT or other medications, check with your doctor before adding any cannabinoid supplement. CBD can affect how certain medications are metabolized. The conversation with your GP may feel awkward. Have it anyway.
From The Canna Company
Exploring CBD or CBG for menopause symptom support? The Canna Company’s tincture lineup is a solid starting point, available in multiple formats and strengths, third-party tested and Oregon-made.